{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:30:44Z","timestamp":1788193844003,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.crad.2022.01.043","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T03:16:56Z","timestamp":1644635816000},"page":"328-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Central nervous system manifestations of systemic haematological malignancies and key differentials"],"prefix":"10.1016","volume":"77","author":[{"given":"A.","family":"Lasocki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2022.01.043_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.crad.2022.01.043_bib2","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2000.18.19.3325","article-title":"Epstein\u2013Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas","volume":"18","author":"Cingolani","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2022.01.043_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneuro0395","article-title":"Primary CNS lymphoma","volume":"3","author":"Hochberg","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.crad.2022.01.043_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood-2013-10-530659","article-title":"Primary testicular lymphoma","volume":"123","author":"Cheah","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.crad.2022.01.043_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejca.2016.12.029","article-title":"The number of extranodal sites assessed by PET\/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: an international multicenter study of 1532 patients treated with chemoimmunotherapy","volume":"75","author":"El-Galaly","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.crad.2022.01.043_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2018.01.073","article-title":"Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma","volume":"93","author":"El-Galaly","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.crad.2022.01.043_bib7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3174\/ajnr.A2171","article-title":"Central nervous system lymphoma: characteristic findings on traditional and advanced imaging","volume":"32","author":"Haldorsen","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.crad.2022.01.043_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.57.3.393","article-title":"MRI features of primary central nervous system lymphomas at presentation","volume":"57","author":"B\u00fchring","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.crad.2022.01.043_bib9","first-page":"5573","article-title":"Role of rCBV values derived from dynamic susceptibility contrast-enhanced magnetic resonance imaging in differentiating CNS lymphoma from high grade glioma: a meta-analysis","volume":"7","author":"Liang","year":"2014","journal-title":"Int J Clin Exper Med"},{"key":"10.1016\/j.crad.2022.01.043_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clml.2015.02.026","article-title":"Influence of rituximab on central nervous system relapse in diffuse large B-cell lymphoma and role of prophylaxis\u2014a systematic review of prospective studies","volume":"15","author":"Ghose","year":"2015","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"key":"10.1016\/j.crad.2022.01.043_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2214\/AJR.14.14092","article-title":"Imaging of nervous system involvement in hematologic malignancies: what radiologists need to know","volume":"205","author":"Keraliya","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2022.01.043_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.blre.2006.02.001","article-title":"CNS prophylaxis in lymphoma: who to target and what therapy to use","volume":"20","author":"Hill","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.crad.2022.01.043_bib13","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","article-title":"Neurolymphomatosis: an international primary CNS lymphoma collaborative group report","volume":"115","author":"Grisariu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.crad.2022.01.043_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1634\/theoncologist.11-5-496","article-title":"Intravascular lymphoma: the oncologist's \u201cgreat imitator\u201d","volume":"11","author":"Zuckerman","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.crad.2022.01.043_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \u201ccutaneous variant\u201d","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crad.2022.01.043_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archneur.59.3.439","article-title":"The neurological masquerade of intravascular lymphomatosis","volume":"59","author":"Beristain","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.crad.2022.01.043_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nic.2016.06.005","article-title":"Lymphomas\u2014part 2","volume":"26","author":"Brand\u00e3o","year":"2016","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.crad.2022.01.043_bib18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3324\/haematol.2015.133744","article-title":"Bing\u2013Neel syndrome, a rare complication of Waldenstrom macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)","volume":"100","author":"Simon","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.crad.2022.01.043_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3816\/CLM.2009.n.028","article-title":"Bing\u2013Neel syndrome revisited","volume":"9","author":"Fintelmann","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.crad.2022.01.043_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00330-018-5543-7","article-title":"Imaging spectrum of Bing\u2013Neel syndrome: how can a radiologist recognise this rare neurological complication of Waldenstrom's macroglobulinemia?","volume":"29","author":"Fitsiori","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2022.01.043_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2141.2011.08573.x","article-title":"Guidelines for the diagnosis and management of multiple myeloma 2011","volume":"154","author":"Bird","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crad.2022.01.043_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.crad.2015.03.014","article-title":"Intracranial involvement by multiple myeloma","volume":"70","author":"Lasocki","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.crad.2022.01.043_bib23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jocn.2020.01.052","article-title":"Retinal ischemia due to extramedullary plasmacytomas of the orbit","volume":"72","author":"Lasocki","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.crad.2022.01.043_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1971400917699426","article-title":"Multiple myeloma of the spine","volume":"30","author":"Lasocki","year":"2017","journal-title":"Neuroradiol J"},{"key":"10.1016\/j.crad.2022.01.043_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood.V42.5.721.721","article-title":"Chloroma and other myeloblastic tumors","volume":"42","author":"Muss","year":"1973","journal-title":"Blood"},{"key":"10.1016\/j.crad.2022.01.043_bib26","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.crad.2022.01.043_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/jcm4051102","article-title":"Intracranial CNS manifestations of myeloid sarcoma in patients with acute myeloid leukemia: review of the literature and three case reports from the author's institution","volume":"4","author":"Cervantes","year":"2015","journal-title":"J Clin Med"},{"key":"10.1016\/j.crad.2022.01.043_bib28","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S1470-2045(17)30031-1","article-title":"Histiocytoses: emerging neoplasia behind inflammation","volume":"18","author":"Haroche","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.crad.2022.01.043_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders","volume":"7","author":"McClain","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.crad.2022.01.043_bib30","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.crad.2022.01.043_bib31","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jnnp-2016-313772","article-title":"MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance","volume":"87","author":"Wijburg","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.crad.2022.01.043_bib32","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1148\/rg.2016160031","article-title":"White matter diseases with radiologic\u2013pathologic correlation","volume":"36","author":"Sarbu","year":"2016","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2022.01.043_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40644-019-0241-5","article-title":"How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology","volume":"19","author":"Lasocki","year":"2019","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.crad.2022.01.043_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.20147","article-title":"Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies","volume":"77","author":"Tam","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crad.2022.01.043_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2019.07.018","article-title":"Posterior reversible encephalopathy syndrome: a review with emphasis on neuroimaging characteristics","volume":"404","author":"Tetsuka","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.crad.2022.01.043_bib36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1148\/rg.323115115","article-title":"Your brain on drugs: imaging of drug-related changes in the central nervous system","volume":"32","author":"Tamrazi","year":"2012","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2022.01.043_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/annonc\/mdm466","article-title":"Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer","volume":"19","author":"Inaba","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.crad.2022.01.043_bib38","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/j.clon.2021.04.010","article-title":"Evaluation of the impact of magnetic resonance imaging with susceptibility-weighted imaging for screening and surveillance of radiation-induced cavernomas in long-term survivors of malignancy","volume":"33","author":"Campbell","year":"2021","journal-title":"Clin Oncol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926022000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926022000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:46:08Z","timestamp":1757868368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926022000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0009926022000526"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2022.01.043","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central nervous system manifestations of systemic haematological malignancies and key differentials","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2022.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}